Psychedelics company Field Trip supports Scott Atkinson’s request for exemption from Canada’s drug laws
With MDMA, patients can revisit and process memories of traumatic experiences
Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
Numinus Wellness chief medical officer Dr. Evan Wood cautions that it’s not a cure for everybody—but trials have shown statistically significant results
Clinical trials of MDMA psychotherapy are going on at 15 sites in the U.S., Canada, and Israel